These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 28102773)
1. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue. Elmi G; Di Pasquale G; Pesavento R Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773 [TBL] [Abstract][Full Text] [Related]
2. The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy. Elmi G; Pizzini AM; Silingardi M Vascular; 2018 Dec; 26(6):670-682. PubMed ID: 29966487 [TBL] [Abstract][Full Text] [Related]
3. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194 [TBL] [Abstract][Full Text] [Related]
4. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Hillis C; Crowther MA Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149 [TBL] [Abstract][Full Text] [Related]
5. Extended anticoagulation after venous thromboembolism: should it be done? Fernandes CJ; Calderaro D; Piloto B; Hoette S; Jardim CVP; Souza R Ther Adv Respir Dis; 2019; 13():1753466619878556. PubMed ID: 31558116 [TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830 [TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858 [TBL] [Abstract][Full Text] [Related]
8. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants. Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach. Black SA; Cohen AT Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864 [TBL] [Abstract][Full Text] [Related]
10. Update on extended treatment for venous thromboembolism. Peñaloza-Martínez E; Demelo-Rodríguez P; Proietti M; Soria Fernández-Llamazares G; Llamazares-Mendo C; Álvarez-Sala Walther L; Marra AM; Del Toro-Cervera J Ann Med; 2018 Dec; 50(8):666-674. PubMed ID: 30345825 [TBL] [Abstract][Full Text] [Related]
11. Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism - Coming to consensus when the debate rages on. Kanthi Y; Piazza G Vasc Med; 2018 Aug; 23(4):384-387. PubMed ID: 29734862 [No Abstract] [Full Text] [Related]
12. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564 [TBL] [Abstract][Full Text] [Related]
13. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice. Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013 [TBL] [Abstract][Full Text] [Related]
14. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough? Prandoni P; Piovella C; Spiezia L; Dalla Valle F; Pesavento R Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115 [TBL] [Abstract][Full Text] [Related]
15. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism. Bauer KA JAMA; 2011 Apr; 305(13):1336-45. PubMed ID: 21386068 [TBL] [Abstract][Full Text] [Related]
16. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials. Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892 [TBL] [Abstract][Full Text] [Related]
17. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism. Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189 [TBL] [Abstract][Full Text] [Related]
18. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis. Djulbegovic M; Lee AI; Chen K J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408 [TBL] [Abstract][Full Text] [Related]